The California company is offering a “groundbreaking” elective imaging exam that equips patients with data on brain function, cognitive health and early indicators of neurodegenerative disease. 

U.S. House Rep. Greg Murphy, MD (R-NC), scolded the CEO of NYU Langone for buying the expensive ad, requesting in an open letter that the hospital release financial data related to its cost. 

Other procedures are associated with higher profits—heart transplants, for instance—but CABG and TAVR are performed much more often.

The FDA recently cleared the company's cable-free, credit card-sized heart monitor that produces 12-lead ECGs.

New data from the Private Equity Stakeholder Project reveals that, while 11% of all-sector bankruptcies were filed by organizations with a history of ownership by investment firms, that number rises to 21% for healthcare. 

If 25% tariffs go into effect, it could have a big impact on the cost of medical imaging and radiotherapy systems, with many manufacturing facilities in Mexico. 

Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus division of stroke products.

The Australian company offers Annalise Enterprise CXR, which leaders believe is the most comprehensive decision aid for X-ray reading, able to identify up to 124 findings.